4.8 Article

A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters

Journal

CELL REPORTS
Volume 4, Issue 3, Pages 578-588

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2013.06.016

Keywords

-

Categories

Funding

  1. NCI [R01 CA104348, R01 CA071540]
  2. NSF CAREER grant [1054964]
  3. Chemotherapy Foundation
  4. Burroughs Wellcome Foundation
  5. Sass Foundation Judah Folkman Fellowship
  6. NHMRC
  7. Monash Larkins Program
  8. CCSRI
  9. Direct For Biological Sciences
  10. Div Of Biological Infrastructure [1054964] Funding Source: National Science Foundation

Ask authors/readers for more resources

The BCL6 transcriptional repressor is required for the development of germinal center (GC) B cells and diffuse large B cell lymphomas (DLBCLs). Although BCL6 can recruit multiple corepressors, its transcriptional repression mechanism of action in normal and malignant B cells is unknown. We find that in B cells, BCL6 mostly functions through two independent mechanisms that are collectively essential to GC formation and DLBCL, both mediated through its N-terminal BTB domain. These are (1) the formation of a unique ternary BCOR-SMRT complex at promoters, with each corepressor binding to symmetrical sites on BCL6 homodimers linked to specific epigenetic chromatin features, and (2) the toggling of active enhancers to a poised but not erased conformation through SMRT-dependent H3K27 deacetylation, which is mediated by HDAC3 and opposed by p300 histone acetyltransferase. Dynamic toggling of enhancers provides a basis for B cells to undergo rapid transcriptional and phenotypic changes in response to signaling or environmental cues.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available